Compare SMTI & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMTI | FVCB |
|---|---|---|
| Founded | 1982 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.2M | 338.0M |
| IPO Year | 2008 | 2018 |
| Metric | SMTI | FVCB |
|---|---|---|
| Price | $35.05 | $17.48 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $35.00 | $19.38 |
| AVG Volume (30 Days) | ★ 154.6K | 53.5K |
| Earning Date | 11-11-2026 | 10-20-2026 |
| Dividend Yield | N/A | ★ 1.59% |
| EPS Growth | N/A | ★ 47.56 |
| EPS | N/A | ★ 0.81 |
| Revenue | ★ $15,586,976.00 | $1,781,000.00 |
| Revenue This Year | $13.07 | $19.14 |
| Revenue Next Year | $14.23 | $9.11 |
| P/E Ratio | ★ N/A | $21.68 |
| Revenue Growth | ★ 32.47 | 13.87 |
| 52 Week Low | $16.05 | $11.83 |
| 52 Week High | $35.34 | $19.11 |
| Indicator | SMTI | FVCB |
|---|---|---|
| Relative Strength Index (RSI) | 62.45 | 37.96 |
| Support Level | $33.99 | $17.28 |
| Resistance Level | $35.34 | $18.97 |
| Average True Range (ATR) | 0.18 | 0.32 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 48.33 | 25.94 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.